Related Experiment Video
Updated: May 5, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Safety evaluation of topical valproate application.
Sun Young Choi1, Song Yi Seop, Moo Yeol Hyun
1Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
Topical valproate (VPA) shows minimal skin irritation potential in human studies. This suggests VPA may be safe for topical application, potentially aiding in hair regrowth treatments.
Area of Science:
- Dermatology and Pharmacology
- Cosmetic Science
Background:
- Topical valproate (VPA) is being explored for hair regrowth.
- Limited safety data exists for topical VPA formulations.
Purpose of the Study:
- To assess the skin irritation potential of topical valproate (VPA) in humans.
- To evaluate the safety of VPA for topical dermatological applications.
Main Methods:
- In vitro cell viability tests on keratinocytes, fibroblasts, and mast cells.
- Clinical patch testing and skin irritation assessments using microneedle rollers for transdermal delivery.
Main Results:
- VPA demonstrated no toxicity to skin cells in vitro.
- Clinical tests showed no significant irritation; one transient erythema case resolved within hours.
- No erythema or edema observed at 24 hours post-application.
Conclusions:
- Topical valproate (VPA) exhibits minimal skin irritation potential.
- VPA is considered safe for topical application on human skin.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Teratogenicity
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drug Regulation
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Prevention of Further Absorption of Poison

